This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
1h Free Analyst TimeSpeak directly to the analyst to clarify any post sales queries you may have.
These gadgets enable healthcare providers to remotely monitor vital signs such as heart rate, blood pressure, oxygen saturation, and breathing rate, allowing for timely interventions and personalised patient care. Germany, France, the United Kingdom, and Italy are leading the way in generating growth in the multiparameter patient monitoring industry. These countries have strong healthcare infrastructures, high healthcare spending, and a favourable regulatory climate that promotes the use of innovative medical technologies. The presence of important businesses, as well as a growing number of startups and research organisations dedicated to expanding monitoring technology, characterises the European market landscape. These organisations are constantly attempting to create cutting-edge gadgets that prioritise patient comfort and ease of use while still ensuring accurate results.
Furthermore, the COVID-19 pandemic has expedited the deployment of remote patient monitoring solutions throughout Europe. The importance of remote monitoring technology has been highlighted by the necessity to minimise in-person interaction while guaranteeing ongoing monitoring of patients, particularly those with chronic diseases. This shift towards remote patient monitoring is projected to continue after the pandemic, fueling additional market expansion in the region.
According to the research report"Europe Multiparameter Patient Monitoring Market Outlook, 2028,", the Europe Multiparameter Patient Monitoring market was valued at USD 3 Billion in 2022. Europe has been instrumental in the development and use of Multiparameter patient monitoring (MPM) technology. Its thriving medical research landscape, various healthcare systems, and strong emphasis on patient safety have produced an ideal environment for innovation and implementation. European researchers and manufacturers have concentrated on building MPM systems that provide a comprehensive picture of a patient's status.
This covers vital signs such as heart rate and blood pressure, as well as advanced metrics like respiratory waveforms and intracranial pressure. Medical devices, particularly MPM systems, are subject to stringent restrictions in the European Union. These restrictions assure high quality and safety standards, which contribute to patient trust and confidence.
MPM technology has been reimbursed in a variety of ways by European healthcare systems. This includes fee-for-service and bundled payment methods, which promote innovation and cost-effectiveness. Regulations such as the General Data Protection Regulation (GDPR) protect patient information in Europe, which places a heavy emphasis on data privacy. This promotes transparency and trust in the application of MPM technology. MPM technology has increased clinical workflow efficiency by allowing healthcare practitioners to access important patient data in real time. This enables speedier decision-making and better patient care coordination. The widespread usage of MPM has resulted in improved patient outcomes in a variety of therapeutic contexts. Early detection of deterioration and prompt care has resulted in lower mortality rates and hospital readmissions.
Based on report market is divided into six major countries, Germany, United Kingdom, France, Italy, Spain and Russia. Germany is projected to lead the Europe Multiparameter patient monitoring market.
Germany is well-known for its technological strength and creativity across a wide range of industries, including healthcare. The country has a strong ecosystem of research institutions, technological firms, and healthcare providers committed to the advancement of medical innovations. This environment promotes the creation of cutting-edge multiparameter patient monitoring devices that place a premium on accuracy, dependability, and creativity. Germany has a regulatory environment that promotes the development and implementation of cutting-edge healthcare technologies. Regulatory organisations in Germany prioritise patient safety while encouraging the adoption of novel medical technologies. This favourable regulatory environment hastens the licencing and deployment of multiparameter patient monitoring devices, allowing for their quick integration into the healthcare system.
Another distinguishing feature of German healthcare is its emphasis on sustainability and environmentally friendly techniques. This mindset extends to the medical device business, where efforts are being made to produce energy-efficient and environmentally friendly monitoring solutions. This pledge is compatible with Germany's broader sustainability efforts and exemplifies the country's all-encompassing approach to innovation. Germany has a universal healthcare system that provides all citizens with high-quality medical care. This strategy encourages the use of cutting-edge technology such as MPM, which allows for more efficient and effective patient monitoring, resulting in improved outcomes and lower healthcare costs.
Companies Covered in this report:
Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton, Dickinson and Company, GE HealthCare Technologies, Inc., Nihon Kohden Corporation, Baxter International Inc., OSI Systems, Inc., Mindray Medical International Limited, Omron Corporation, Schiller AG.Considered in this report:
- Geography: Europe
- Historic year: 2017
- Base year: 2022
- Estimated year: 2023
- Forecast year: 2028
Aspects covered in this report:
- Europe Multiparameter Patient Monitoring market Outlook with its value and forecast along with its segments
- Country-wise Multiparameter Patient Monitoring market analysis
- Various drivers and challenges
- On-going trends and developments
- Top profiled companies
- Strategic recommendation
Country covered in the report:
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
By Device:
- Portable
- Fixed
By Acuity Level:
- High-Acuity Level
- Medium Acuity Level
- Low Acuity Level
By End User:
- Hospital
- Homecare Settings
- Ambulatory Surgical Centers
The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Multiparameter Patient Monitoring industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.
This product will be delivered within 2 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Medtronic plc
- Koninklijke Philips N.V.
- Becton, Dickinson and Company
- GE HealthCare Technologies, Inc.
- Nihon Kohden Corporation
- Baxter International Inc.
- OSI Systems, Inc.
- Mindray Medical International Limited
- Omron Corporation
- Schiller AG
- Masimo Corporation